CymaBay Announces Proposed Public Offering of Common Stock

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/15/2026

1. BAC
2. DPZ
3. NVDA
4. DRS
5. GS
6. JPM
7. ACI
8. ORCL
9. AVAV
10. VSTM

Go back to CymaBay Announces Proposed Public Offering of Common Stock

CymaBay Therapeutics (CBAY) Prices 8M Common Stock Offering at $12.50/Share

March 6, 2019 8:04 AM EST

CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases with high unmet medical need, today announced the pricing of its previously announced underwritten public offering of... More

CymaBay Therapeutics (CBAY) Offering is Said to Price at $12.50/Share - Bloomberg

March 6, 2019 6:56 AM EST

CymaBay Therapeutics (NASDAQ: CBAY) Offering is Said to Price at $12.50/Share - Bloomberg

... More